A Comparative Histopathological Study of Heparin Coated and Uncoated Polytetrafluoroethylene Shunts in Children With Congenital Heart Defect
暂无分享,去创建一个
R. Lange | G. Balling | J. Hörer | C. Schreiber | J. Cleuziou | M. Sigler | R. Foth | J. Kašnar-Šamprec
[1] C. Male,et al. Anticoagulation in Children Undergoing Cardiac Surgery , 2011, Seminars in thrombosis and hemostasis.
[2] Martin Glöckler,et al. Early obstruction of decellularized xenogenic valves in pediatric patients: involvement of inflammatory and fibroproliferative processes. , 2011, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[3] E. Mattsson,et al. Improved patency and reduced intimal hyperplasia in PTFE grafts with luminal immobilized heparin compared with standard PTFE grafts at six months in a sheep model. , 2010, The Journal of cardiovascular surgery.
[4] James M. Anderson,et al. Foreign body reaction to biomaterials. , 2008, Seminars in immunology.
[5] Bradford J. Kim,et al. Two thousand Blalock-Taussig shunts: a six-decade experience. , 2007, The Annals of thoracic surgery.
[6] N. B. Lerner,et al. Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgery. , 2007, The Annals of thoracic surgery.
[7] R. Califf,et al. Clinical Outcomes of Palliative Surgery Including a Systemic-to-Pulmonary Artery Shunt in Infants With Cyanotic Congenital Heart Disease: Does Aspirin Make a Difference? , 2007, Circulation.
[8] R. Lange,et al. Early graft failure of small-sized porcine valved conduits in reconstruction of the right ventricular outflow tract. , 2006, The Annals of thoracic surgery.
[9] Dr. M. Sigler,et al. Biocompatibility screening in cardiovascular implants , 2005, Zeitschrift für Kardiologie.
[10] A. Lumsden,et al. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model. , 2004, Journal of vascular surgery.
[11] H. Sievert,et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. , 2004, Journal of the American College of Cardiology.
[12] F. Pigula,et al. Interim mortality in infants with systemic-to-pulmonary artery shunts. , 2003, The Annals of thoracic surgery.
[13] S. Rafii,et al. Contribution of marrow-derived progenitors to vascular and cardiac regeneration. , 2002, Seminars in cell & developmental biology.
[14] J. Monro,et al. Twelve year experience with the modified Blalock-Taussig shunt in neonates. , 1992, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[15] K. Watterson,et al. Very small pulmonary arteries: central end-to-side shunt. , 1991, The Annals of thoracic surgery.
[16] S. Moncada,et al. The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide , 1987, British journal of pharmacology.
[17] D. Gibbons,et al. Effect of implant surface chemistry upon arterial thrombosis. , 1979, Journal of biomedical materials research.
[18] H. Taussig,et al. The Surgical Treatment of Malformations of the Heart: In Which There Is Pulmonary Stenosis or Pulmonary Atresia , 1945 .